We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byKylie Zimmerman
Modified over 2 years ago
© IFPMA 2009ECOSOC R&D and Access 08 July 2009 Access, Capacity Building and R&D: IFPMA Member Company Programs to help improve Health in Developing Countries ECOSOC, Geneva, 8 July 2009
© IFPMA 2009ECOSOC R&D and Access 08 July Growing Industry Effort to help achieve MDGs Additional Initiatives Chronic Diseases Child & Maternal Preventable Diseases Tropical Diseases MalariaMalaria TuberculosisTuberculosis HIV/AIDSHIV/AIDS Section TOTALS (26)(26) (202)
© IFPMA 2009ECOSOC R&D and Access 08 July Industry Programs for Access… and more Industry Partnerships to Improve Health in Developing World What the programs are doing: Access (36 % of all programs)Access (36 % of all programs) Capacity-Building (55 % of all programs)Capacity-Building (55 % of all programs) Education (32 % of all programs)Education (32 % of all programs) R&D for DDW* (23 % of all programs)R&D for DDW* (23 % of all programs) (* DDW = Diseases of the Developing World) (NOTE: Many programs have more than 1 area of activity)
© IFPMA 2009ECOSOC R&D and Access 08 July Example: HIV / AIDS Abbott, Boehringer-Ingelheim, Johnson & Johnson Abbott, Boehringer-Ingelheim, Johnson & Johnson Partners: Elizabeth Glaser Pediatric AIDS Foundation Partners: Elizabeth Glaser Pediatric AIDS Foundation Access – Donation Access – Donation Capacity Building – Training Capacity Building – Training Education Education In 17 Developing Countries In 17 Developing Countries Elizabeth Glaser Pediatric AIDS Foundation Trains Health WorkersTrains Health Workers HIV counselingHIV counseling Prevention educationPrevention education Infant feeding educationInfant feeding education Donation of ARVs for PMTCTDonation of ARVs for PMTCT Donation of rapid test kitsDonation of rapid test kits
© IFPMA 2009ECOSOC R&D and Access 08 July Example: Tuberculosis Eli Lilly and Company Eli Lilly and Company Partners: WHO & Others Partners: WHO & Others Access – Pricing & Licensing Access – Pricing & Licensing Capacity Building – Support & Training Capacity Building – Support & Training Education Education In 60 developing countries In 60 developing countries Lilly MDR-TB Partnership Access to medicinesAccess to medicines Production Technology TransferProduction Technology Transfer Training Health WorkersTraining Health Workers Disease SurveillanceDisease Surveillance Educating People at RiskEducating People at Risk Community SupportCommunity Support
© IFPMA 2009ECOSOC R&D and Access 08 July Example: Malaria Pfizer Pfizer Partner: London School of Hygiene & Tropical Medicine, KEMRI- Wellcome Trust, Health Partners Ghana & others Partner: London School of Hygiene & Tropical Medicine, KEMRI- Wellcome Trust, Health Partners Ghana & others Capacity Building – Support & Training Capacity Building – Support & Training In Ghana, Kenya, Senegal In Ghana, Kenya, Senegal Mobilize Against Malaria Training Health WorkersTraining Health Workers Technical AssistanceTechnical Assistance Material supportMaterial support Sharing Best PracticesSharing Best Practices
© IFPMA 2009ECOSOC R&D and Access 08 July Example: Tropical Diseases Merck KGaA Merck KGaA Partner: Programme for Research & Training in Tropical Diseases (TDR), sponsored by UNICEF, UNDP, World Bank & WHO Partner: Programme for Research & Training in Tropical Diseases (TDR), sponsored by UNICEF, UNDP, World Bank & WHO Research & Development Research & Development Merck Serono Collaboration with TDR Training ResearchersTraining Researchers Malaria & Sleeping SicknessMalaria & Sleeping Sickness Screening Compound LibraryScreening Compound Library Identify new Lead MoleculesIdentify new Lead Molecules
© IFPMA 2009ECOSOC R&D and Access 08 July Example: Preventable Diseases Crucell, GlaxoSmithKline, Merck & Co, sanofi-aventis, Wyeth Crucell, GlaxoSmithKline, Merck & Co, sanofi-aventis, Wyeth Partners: GAVI Alliance, WHO & other partners Partners: GAVI Alliance, WHO & other partners Access – Donation & Pricing Access – Donation & Pricing Capacity Building – Support & Training Capacity Building – Support & Training In many low-income countries In many low-income countries GAVI Alliance Existing / new vaccines to LDCsExisting / new vaccines to LDCs Preferential pricing of vaccinesPreferential pricing of vaccines Donation of vaccinesDonation of vaccines Technical & Training SupportTechnical & Training Support
© IFPMA 2009ECOSOC R&D and Access 08 July Example: Child & Maternal Health Schering-Plough Schering-Plough Partners: WHO Regional Office for Africa, International Federation of Gynecology & Obstetrics (FIGO) Partners: WHO Regional Office for Africa, International Federation of Gynecology & Obstetrics (FIGO) Capacity Building – Training Capacity Building – Training 10 countries in Africa & Latin America 10 countries in Africa & Latin America Postpartum Hemorrhage Training Material Postpartum management guidePostpartum management guide For low resource environmentsFor low resource environments Complementary posters, etc.Complementary posters, etc. In English, French & SpanishIn English, French & Spanish
© IFPMA 2009ECOSOC R&D and Access 08 July Example: Chronic Diseases Novo Nordisk & Roche Novo Nordisk & Roche Partners: World Diabetes Federation, Ministries of Health & patient organizations Partners: World Diabetes Federation, Ministries of Health & patient organizations Access – Donation Access – Donation Capacity Building – Support & Training Capacity Building – Support & Training Cameroon, DR Congo, Guinea, Tanzania, Uganda Cameroon, DR Congo, Guinea, Tanzania, Uganda Changing Diabetes in Children Develop infrastructureDevelop infrastructure Train Health WorkersTrain Health Workers Guidelines & Education MaterialGuidelines & Education Material Medicines & Medical SuppliesMedicines & Medical Supplies
© IFPMA 2009ECOSOC R&D and Access 08 July Example: Additional Health Initiatives Japanese Pharmaceutical Manufacturers Association (JPMA) Japanese Pharmaceutical Manufacturers Association (JPMA) Partners: WHO, Thailand Ministry of Health Partners: WHO, Thailand Ministry of Health Capacity Building – Support & Training Capacity Building – Support & Training Bhutan, Cambodia, Laos, Thailand Bhutan, Cambodia, Laos, Thailand Strengthening Quality Control in SE Asia Improve Medicine QualityImprove Medicine Quality Train Government PersonnelTrain Government Personnel Provide Analytical InstrumentsProvide Analytical Instruments Supply Reference SubstancesSupply Reference Substances
© IFPMA 2009ECOSOC R&D and Access 08 July Search by Developing Country: Kenya 43 programs found
© IFPMA 2009ECOSOC R&D and Access 08 July Find Details of Partner Organizations that Industry works with in different areas…
© IFPMA 2009ECOSOC R&D and Access 08 July Number of Active Research and Development Projects* *1 project = 1 compound in development or 1 screening program for 1 disease Medicine R&D projects Vaccine R&D projects Source: IFPMA IFPMA Status Report on DDW R&D R&D for TDR 10 Priority Diseases: - Chagas - Dengue - Human African Trypanosomiasis - Leishmaniasis - Leprosy - Lymphatic Filariasis - Malaria - Onchocerciasis - Schistosomiasis - Tuberculosis
© IFPMA 2009ECOSOC R&D and Access 08 July Overview of R&D Projects by Disease Area – 2009 Disease Ongoing Medicines R&D Projects Ongoing Vaccines R&D Projects Approvals Since 2005 R&D Projects Stopped Since 2005 Tuberculosis22306 Malaria Other Tropical Diseases Totals759520
© IFPMA 2009ECOSOC R&D and Access 08 July Developing World Disease R&D Funders 2007 US Government 48.9 % US Government 48.9 % Bill & Melinda Gates Foundation 17.7 % Pharma Industry 9.1 % European Commission 4.7 % United Kingdom (Govt) 3.9 % Wellcome Trust 2.3 % Netherlands (Govt) 1.3 % Pasteur Institute 1.2% Ireland (Govt) 0.9 % Brazil (Govt) 0.9 % Sweden (Govt) 0.8 % Canada (Govt) 0.7% Australia (Govt) 0.7 % Russia (Govt) 0.7 % Belgium (Govt) 0.6 % France (Govt) 0.5 % South Africa (Govt) 0.2 % All Other Philanthropic 1.0 % All Other Govts 4.4 % Source: G-FINDER, George Institute, 2009 © IFPMA 2009ECOSOC R&D and Access 08 July 2009
© IFPMA 2009ECOSOC R&D and Access 08 July Terms to search for: Malaria & Vaccine Trials conducted in: Kenya
© IFPMA 2009ECOSOC R&D and Access 08 July 2009 Thank You! Ch. Louis-Dunant 15 P.O. Box Geneva 20 Switzerland Tel: Fax: Web:www.ifpma.org
© IFPMA 2009 IFPMA to WHO EWG 12 Jan 09 1 Alicia D. Greenidge, Director General, IFPMA WHO Expert Working Group, Geneva, 12 Jan 2009 IFPMA Presentation.
1 Department of Medicines Policy and Standards, Health Technology and Pharmaceuticals Prequalification of Essential Medicines Dr Lembit Rägo Coordinator.
Financing and Coordination of R&D for neglected diseases: Challenges and opportunities Consultative Expert Working Group on Research and Development Open.
Geneva, Switzerland, September 2012 Narrowing the Evidence gap for informed policy and regulations in mHealth Dr. Shariq Khoja MD. PhD (eHealth)
1 WG on GSPA Financing Jan 12-13, 2009 Public Private Partnerships for Product Development Platforms, Lessons and Challenges for GSPA Robert Ridley Director,
Food Assistance Programming in the Context of HIV Why was the guide written? How is the Guide organized? What is in plan next 10 months? Kenton Kayira.
WHO Norms and Standards: Blood Products & related Biologicals Dr Ana Padilla Blood Products & related Biologicals Quality and Safety: Medicines Essential.
R&D Financing by the Bill & Melinda Gates Foundation PRESENTED BY Neil McDonnell, Pharm.D. January 12, 2009 WHO Expert Working Group on R&D Financing.
PREQUALIFICATION General overview and procedures and practical implications of WHO PQ, FDA registration, registration with PICs member countries for procurement.
WHO-Technical Briefing Seminar | 03 November 2010 Gilles Forte 1 |1 | WHO Technical Briefing Seminar Geneva November WHO Collaboration with.
Pharmacovigilance Shanthi Pal, M.Pharmacy, PhD Quality Assurance and Safety of Medicines WHO.
1 Dr. Zhu CHEN Minister of Health, China (8 July 2009, Geneva) Health-related MDGs in China 1.
Blindness prevention and NTDs: Building platforms, raising profiles and learning lessons-recipes for success Professor David Molyneux, Centre for Neglected.
Figure 2008 Report on the global AIDS epidemic Selected events in the global response to the epidemicUniversalAccessTargets MillenniumDevelopmentGoals.
WHO Strategy on Research for Health Rob Terry – Project Manager, RPC.
Funding in Return for Rights Outside the Developed World: Public-Private Partnerships Gerald J. Siuta, Ph.D. Consultant, Business Development September.
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps…
UNITAID WHO EXPERT WORKING GROUP ON R&D* FINANCING Geneva, 13 January 2009 Dr. Philippe Douste-Blazy, Chairman, UNITAID.
World Bank Seminar Series: Global Issues Facing Humanity Diseases without borders PART I.
WHO STRATEGY FOR WORKING WITH COUNTRIES:REGIONAL AND COUNTRY PERSPECTIVE TECHNICAL BRIEFING SEMINAR,Geneva,19-23 September 2005 Dr. Jean-Marie TRAPSIDA.
1 World Bank Training Program on Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies Financing and Pricing based on the World Bank.
Briefing on TBS Training course 18 Sep 2006 Geneva 1 Dr Xiaorui Zhang Coordinator Traditional Medicine Department of Essential Drugs and Traditional Medicine.
UNICEF-EC Toolkit Background Paper on Social Budgeting Draft Radhika Gore February 19, UNICEF-EC Child Rights Toolkit Chapter on Social Budgeting.
UNDP and General Obligations of the Framework Convention on Tobacco Control Douglas Webb HIV, Health and Development Group Bureau for Development Policy.
1 Advocacy, Communication and Social Mobilization Using ACSM to maximize civil society engagement in GFATM projects.
Page 1 Raising the priority of noncommunicable diseases in development work at global and national levels Presentation for discussion (Not an official.
World Health Day No action today, no cure tomorrow 7 April 2011 | World Health Day Why AMR is a global concern? Antimicrobial resistance (AMR)
Challenges for the WHO Programme for International Drug Monitoring Shanthi Pal Quality Assurance and Safety of Medicines Cecilia Biriell Reports, Analysis.
Click to edit Master title style Click to edit Master subtitle style 12/31/20131 Slide 1 January 2010 Slide 1 January 2010 How to Cure the EU Patient Information.
Enhancing trade between Arab and African countries Troisième Réunion des Chambres de Commerce et dIndustrie dAfrique et du Monde Arabe,Rabat – Maroc,
© 2016 SlidePlayer.com Inc. All rights reserved.